The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
12
Identification of novel inverse agonists of estrogen-related receptors ERR¿ and ERRß.EBI
The Beckman Research Institute
28
Synthesis and biological evaluation of novel 4-hydroxytamoxifen analogs as estrogen-related receptor gamma inverse agonists.EBI
Daegu-Gyeongbuk Medical Innovation Foundation
41
An orally available inverse agonist of estrogen-related receptor gamma showed expanded efficacy for the radioiodine therapy of poorly differentiated thyroid cancer.EBI
Daegu-Gyeongbuk Medical Innovation Foundation
45
Insights of a Lead Optimization Study and Biological Evaluation of Novel 4-Hydroxytamoxifen Analogs as Estrogen-Related Receptor γ (ERRγ) Inverse Agonists.EBI
Daegu-Gyeongbuk Medical Innovation Foundation
36
Discovery of Potent, Selective, and Orally Bioavailable Estrogen-Related Receptor-γ Inverse Agonists To Restore the Sodium Iodide Symporter Function in Anaplastic Thyroid Cancer.EBI
Daegu-Gyeongbuk Medical Innovation Foundation
34
Design, synthesis, and evaluation of simple phenol amides as ERRγ agonists.EBI
The Scripps Research Institute
34
Indazole-based ligands for estrogen-related receptor α as potential anti-diabetic agents.EBI
Janssen Research and Development
55
MAPK inhibitorsBDB
Everbrilliant Pharma
69
Intermediate compound of novel tetrahydronaphthyl urea derivativeBDB
Mochida Pharmaceutical
139
Biaryl-propionic acid derivatives and their use as pharmaceuticalsBDB
Sanofi